Browsing by Author "Dolor, Rowena J"
Now showing items 1-8 of 8
-
A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation.
Samsa, Greg; Matchar, David B; Dolor, Rowena J; Wiklund, Ingela; Hedner, Ewa; Wygant, Gail; Hauch, Ole; ... (9 authors) (Health Qual Life Outcomes, 2004-05-06)BACKGROUND: Anticoagulation can reduce quality of life, and different models of anticoagulation management might have different impacts on satisfaction with this component of medical care. Yet, to our knowledge, there are ... -
An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).
Dolor, Rowena J; Ruybalid, R Lynne; Uyeda, Lauren; Edson, Robert G; Phibbs, Ciaran; Vertrees, Julia E; Shih, Mei-Chiung; ... (10 authors) (Journal of thrombosis and thrombolysis, 2010-10)Prior studies suggest patient self-testing (PST) of prothrombin time (PT) can improve the quality of anticoagulation (AC) and reduce complications (e.g., bleeding and thromboembolic events). "The Home INR Study" (THINRS) ... -
Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
Ladapo, Joseph A; Hoffmann, Udo; Lee, Kerry L; Coles, Adrian; Huang, Megan; Mark, Daniel B; Dolor, Rowena J; ... (12 authors) (J Am Heart Assoc, 2016-10-12)BACKGROUND: Diagnostic testing in the care of patients newly presenting with symptoms suggestive of coronary artery disease may influence risk factor management, independent of test type or test results. However, little ... -
Hypertension Improvement Project (HIP): study protocol and implementation challenges.
Dolor, Rowena J; Yancy, William S; Owen, William F; Matchar, David B; Samsa, Gregory P; Pollak, Kathryn I; Lin, Pao-Hwa; ... (13 authors) (Trials, 2009-02-26)<h4>Background</h4>Hypertension affects 29% of the adult U.S. population and is a leading cause of heart disease, stroke, and kidney failure. Despite numerous effective treatments, only 53% of people with hypertension are ... -
Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
Sherwood, Matthew W; Melloni, Chiara; Jones, W Schuyler; Washam, Jeffrey B; Hasselblad, Vic; Dolor, Rowena J (J Am Heart Assoc, 2015-10-29)BACKGROUND: Observational studies evaluating the possible interaction between proton pump inhibitors (PPIs) and clopidogrel have shown mixed results. We conducted a systematic review comparing the safety of individual PPIs ... -
Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates.
Walter, Emmanuel B; Allred, Norma J; Swamy, Geeta K; Hellkamp, Anne S; Dolor, Rowena J (Infect Control Hosp Epidemiol, 2010-10)We implemented a hospital-based influenza vaccination program for household contacts of newborns. Among mothers not vaccinated prenatally, 44.7% were vaccinated through the program, as were 25.7% of fathers. A hospital-based ... -
Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial.
Edelman, David; Dolor, Rowena J; Coffman, Cynthia J; Pereira, Katherine C; Granger, Bradi B; Lindquist, Jennifer H; Neary, Alice M; ... (9 authors) (J Gen Intern Med, 2015-05)BACKGROUND: Several trials have demonstrated the efficacy of nurse telephone case management for diabetes (DM) and hypertension (HTN) in academic or vertically integrated systems. Little is known about the real-world potency ... -
The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial.
Matchar, David B; Love, Sean R; Jacobson, Alan K; Edson, Robert; Uyeda, Lauren; Phibbs, Ciaran S; Dolor, Rowena J (Journal of thrombosis and thrombolysis, 2015-07)Anticoagulation (AC) is effective in reducing thromboembolic events for individuals with atrial fibrillation (AF) or mechanical heart valve (MHV), but maintaining patients in target range for international normalized ratio ...